Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy

Chin Med J (Engl). 2022 Jul 20;135(14):1639-1641. doi: 10.1097/CM9.0000000000002288.
No abstract available

MeSH terms

  • Blood Coagulation Disorders* / therapy
  • Cell- and Tissue-Based Therapy
  • China
  • Consensus
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen* / therapeutic use

Substances

  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen